Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition-Reference-Cited by-同舟云学术

Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition

Published:2024-05 Issue:3 Volume:62 Page:402-418
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Bando Masashi^ORCID,Homma Sakae,Date Hiroshi,Kishi Kazuma,Yamauchi Hiroyoshi,Sakamoto Susumu,Miyamoto Atsushi,Goto Yoshihito,Nakayama Takeo,Azuma Arata,Kondoh Yasuhiro,Johkoh Takeshi,Nishioka Yasuhiko,Fukuoka Junya,Miyazaki Yasunari,Yoshino Ichiro,Suda Takafumi

Publisher

Elsevier BV

Reference122 articles.

1. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement;Am J Respir Crit Care Med,2000

2. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

3. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline;Raghu;Am J Respir Crit Care Med,2015

4. Japanese guideline for the treatment of idiopathic pulmonary fibrosis;Homma;Respir Investig,2018

5. TOLLIP, MUC5B, and the response to N-acetylcysteine among individuals with idiopathic pulmonary fibrosis;Oldham;Am J Respir Crit Care Med,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in the diagnosis and management of idiopathic pulmonary fibrosis in Japan;Respiratory Investigation;2024-09

2. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

3. Lung Cancer and Interstitial Lung Diseases;Cancers;2024-08-13